Thank you, Madam Chair.
With all due respect, I disagree with my colleague. Most of the witnesses we've heard believe that this bill is an important one, that we should be moving forward, and that there are some issues they would like to see addressed where they have concerns. To characterize it as a mess is perhaps overstating some issues that could perhaps be worked out through the committee process.
We've heard one suggestion from Mrs. Wasylycia-Leis about risk level 2 pathogens. We heard from the health agency that they were really only looking at an inventory and general safety necessities around those risk level 2s. So if you had something like that written around risk level 2 that was very specific about what it would entail in the act--that it was very different from levels 3 and 4--would that not be a good approach? As you said earlier, we have many different types of labs in many different provinces with different things happening. Would that be an approach to take with risk level 2, clearly defining their interests around inventory and a few other more generic things?
I'd like feedback from everyone.
Thanks.